Covered recipient · General Payments record
DOUGLAS PAUL COLLINS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,193.36
- Reported across 62 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $478.26 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $245.43 | 12 |
| Cranial Technologies, Inc | $37.62 | 2 |
| Merck Sharp & Dohme Corporation | $35.91 | 2 |
| PFIZER INC. | $34.51 | 2 |
| Supernus Pharmaceuticals, Inc. | $33.82 | 1 |
| Indivior Inc. | $33.80 | 2 |
| Exact Sciences Corporation | $15.95 | 1 |
| Lilly USA, LLC | $14.76 | 1 |
| Acerta Pharma LLC | $13.38 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $13.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.92 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491905 | CMS |
| ABBVIE INC. | $17.61 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491907 | CMS |
| ABBVIE INC. | $19.52 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491909 | CMS |
| ABBVIE INC. | $24.14 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491911 | CMS |
| ABBVIE INC. | $20.30 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491913 | CMS |
| ABBVIE INC. | $28.82 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491915 | CMS |
| ABBVIE INC. | $4.00 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491917 | CMS |
| ABBVIE INC. | $30.52 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491919 | CMS |
| ABBVIE INC. | $16.40 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491921 | CMS |
| ABBVIE INC. | $29.65 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491923 | CMS |
| ABBVIE INC. | $12.39 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491925 | CMS |
| ABBVIE INC. | $17.16 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491927 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.38 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104348310 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $13.08 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086113932 | CMS |
| Cranial Technologies, Inc | $18.63 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082216756 | CMS |
| Cranial Technologies, Inc | $18.99 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082216758 | CMS |
| Exact Sciences Corporation | $15.95 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114619779 | CMS |
| Indivior Inc. | $14.98 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144526096 | CMS |
| Indivior Inc. | $18.82 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144526098 | CMS |
| Lilly USA, LLC | $14.76 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136162559 | CMS |
| Merck Sharp & Dohme LLC | $18.89 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141971251 | CMS |
| Merck Sharp & Dohme LLC | $17.02 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141963759 | CMS |
| PFIZER INC. | $17.48 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131117537 | CMS |
| PFIZER INC. | $17.03 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131080169 | CMS |
| Supernus Pharmaceuticals, Inc. | $33.82 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147891940 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.